Sentry BioPharma Services Earns a GSA Federal Supply Schedule Contract #GS-10F-0432X
Sentry enhances its ability to secure government service contracts for temperature-controlled vaccine and pharmaceutical storage and biopharmaceutical logistics.
INDIANAPOLIS, Ind., Oct. 18, 2011 /PRNewswire/ -- Sentry BioPharma Services, a provider of global biopharmaceutical cGMP storage, supply chain management, prescription drug distribution and clinical packaging services, announced today that they have signed a five-year contract with the General Service Administration for inclusion on the Federal Supply Schedule, Logistics Worldwide (LogWorld). Inclusion on this schedule will help Sentry BioPharma secure no bid contracts with many federal government agencies for the provision of temperature-controlled storage and distribution of vaccines and pharmaceutical products.
When asked about the significance of this contract, Ms. Jennifer Marcum, Sentry's CEO, stated that "earning a GSA Contract is not only a testament to Sentry BioPharma's expertise as a biopharmaceutical warehousing and logistics provider and its ability to expeditiously implement key projects. It is also a validation of our international services, as the application process includes an extensive review of Sentry's prior experience with temperature-controlled vaccine and pharmaceutical storage and logistics, as well as a survey of our clients' satisfaction with our company." Marcum further elaborated by stating that "Sentry's biopharmaceutical storage and drug distribution services are perfectly designed and constructed to support any government agency's needs for the cGMP storage, labeling, kitting and distribution of temperature-sensitive pharmaceutical products, including vaccines and regulated medications." Finally, Marcum stressed that "by investing the resources to complete the GSA contracting process, Sentry expects to gain efficiencies when contracting with federal agencies like Department of Defense (DOD), the Centers for Disease Control and Prevention (CDC) and the Department of Veterans Affairs (VA)." Additional information regarding Sentry's GSA Contract can be found at GSA eLibrary.
About Sentry BioPharma Services
Sentry BioPharma Services maintains cGMP temperature-controlled storage for vaccine and other biopharmaceutical product, FDA labeling capability, drug distribution licenses and an active Foreign Trade Zone status to exclusively serve the global pharmaceutical, biotechnology and health care industries. Its facilities, infrastructure and services are specifically designed to meet the cGMP warehousing, packaging, cold chain logistics and contract service needs of pharmaceutical and biotech firms, health care providers and suppliers, contract research organizations (CROs), contract manufacturing organizations (CMOs), wholesalers, distributors and government entities.
Sentry's management team offers expertise in pharmaceutical cold chain storage and logistics, quality assurance, biopharmaceutical packaging and kitting development. Sentry also offers strategic solutions for global transportation and logistics, as well as end-to-end import and export management.
The company's validated processes and inventory tracking systems are FDA compliant, adhere to current Good Manufacturing Practices (cGMPs) and comply with stringent standard operating procedures (SOPs) outlined in Sentry's Validation Master Plan. Sentry is VAWD® accredited, which ensures its storage, handling and distribution methods meet the recognized guidelines of the National Association of Boards of Pharmacy®. The company is privately held and strategically headquartered in Indianapolis, Indiana.
Ms. April L. Lentz
Sentry BioPharma Services, Inc.
Phone: (866) 757-7400 ext. 107
Email: [email protected]
SOURCE Sentry BioPharma Services, Inc.